---
figid: PMC4970823__CAS-107-569-g002
figtitle: Regulation of cancer cell functions by hyaluronan (HA)‐receptor interactions
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
pmcid: PMC4970823
filename: CAS-107-569-g002.jpg
figlink: /pmc/articles/PMC4970823/figure/cas12913-fig-0002/
number: F2
caption: Regulation of cancer cell functions by hyaluronan (HA)‐receptor interactions.
  Binding of HA to CD44 has been shown to activate MAPK, Rac, and phosphoinositide
  3‐kinase (PI3K) signaling, leading to enhanced cell survival, proliferation, migration,
  and invasion. The activated PI3K pathway also activates multidrug resistance 1 (MDR1)
  to mediate multidrug resistance. Receptor for HA‐mediated motility (RHAMM) is known
  to induce focal adhesion kinase (FAK) and also interacts with CD44 to enhance MAPK
  activity. HA binding to CD44 variant 10 (CD44v10) induces CD44v10–ephrinA2 receptor
  (EphA2) complex formation, resulting in RhoA activation and angiogenesis. Akt, protein
  kinase B; PATJ, Pals1‐associated tight junction.
papertitle: 'Role of hyaluronan in pancreatic cancer biology and therapy: Once again
  in the spotlight.'
reftext: Norihiro Sato, et al. Cancer Sci. 2016 May;107(5):569-575.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9652483
figid_alias: PMC4970823__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Bos taurus
redirect_from: /figures/PMC4970823__F2
ndex: 3d4f8e91-decc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4970823__CAS-107-569-g002.html
  '@type': Dataset
  description: Regulation of cancer cell functions by hyaluronan (HA)‐receptor interactions.
    Binding of HA to CD44 has been shown to activate MAPK, Rac, and phosphoinositide
    3‐kinase (PI3K) signaling, leading to enhanced cell survival, proliferation, migration,
    and invasion. The activated PI3K pathway also activates multidrug resistance 1
    (MDR1) to mediate multidrug resistance. Receptor for HA‐mediated motility (RHAMM)
    is known to induce focal adhesion kinase (FAK) and also interacts with CD44 to
    enhance MAPK activity. HA binding to CD44 variant 10 (CD44v10) induces CD44v10–ephrinA2
    receptor (EphA2) complex formation, resulting in RhoA activation and angiogenesis.
    Akt, protein kinase B; PATJ, Pals1‐associated tight junction.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cd44
  - Hmmr
  - Abcb1b
  - Mod2
  - Epha2
  - Patj
  - Mcf2l
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Ptk2
  - Akt1
  - Rho
  - Rhod
  - Ea2
  - Mdk
  - Ephb2
  - Mapk1
  - CD44
  - HMMR
  - ABCB1
  - TBC1D9
  - EPHA2
  - PATJ
  - LRP2
  - PRH1
  - MCF2L
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTK2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTG1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - Cancer
---
